Neurocrine Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2022
Total Assets: $2.37B
Liabilities Breakdown FY2022
Total Liabilities: $660.9M
Asset Breakdown
Total Assets: $2.37B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $262.9M | 11.1% |
| Accounts Receivable | $350.0M | 14.8% |
| Inventory | $35.1M | 1.5% |
| Property, Plant & Equipment | $58.6M | 2.5% |
| Goodwill | $5.4M | 0.2% |
| Intangible Assets | $37.2M | 1.6% |
| Other Assets | $1.62B | 68.4% |
Liabilities Breakdown
Total Liabilities: $660.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $0 | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $660.9M | 100.0% |